Analyst price target range
Cogent Biosciences Price Target: $55.82 Average
Direct answer
Cogent Biosciences's average price target is $55.82.
The verified analyst range runs from $45.00 to $62.00.
The low target implies +42.9%, the high target implies +96.8%, and the range spans 54% of the current price.
Forecast evidence checked September 19, 2026.
Get free Cogent Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $31.50
- Average price target
- $55.82
- High price target
- $62.00
- Low price target
- $45.00
- Low target gap
- +42.9%
- Target upside
- +77.2%
- High target gap
- +96.8%
- Target range width
- 54%
- Consensus rating
- Strong Buy
- Analysts
- 11
- Evidence date
- September 19, 2026
- Valid through
- September 26, 2026
Explore related company data
Read the frequently asked questions.
What is Cogent Biosciences's average price target?
Cogent Biosciences's verified average price target is $55.82. The target range is $45.00 to $62.00.
How far are Cogent Biosciences's low and high targets from the recorded price?
The low target implies +42.9%, while the high target implies +96.8%.
How many analysts are included in Cogent Biosciences's consensus?
The verified consensus includes 11 analysts.
How is Cogent Biosciences's target upside or downside calculated?
The average target of $55.82 is divided by the recorded price of $31.50, then one is subtracted to produce +77.2%. This does not guarantee a future return.
When was Cogent Biosciences's analyst forecast verified?
The data was verified on 2026-09-19. The dataset is valid through 2026-09-26.